These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 23237308

  • 1. The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas.
    Kim C, Bi X, Pan D, Chen Y, Carling T, Ma S, Udelsman R, Zhang Y.
    Thyroid; 2013 May; 23(5):575-82. PubMed ID: 23237308
    [Abstract] [Full Text] [Related]

  • 2. Second primaries after major salivary gland cancer.
    Megwalu UC, Shin EJ.
    Otolaryngol Head Neck Surg; 2011 Aug; 145(2):254-8. PubMed ID: 21493280
    [Abstract] [Full Text] [Related]

  • 3. Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.
    Marti JL, Jain KS, Morris LG.
    Thyroid; 2015 Jun; 25(6):681-7. PubMed ID: 25851829
    [Abstract] [Full Text] [Related]

  • 4. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working GroupAIRTUM Working Group: tumori.infantili@registri-tumori.it..
    Epidemiol Prev; 2013 Jun; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [Abstract] [Full Text] [Related]

  • 5. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
    Spanogle JP, Clarke CA, Aroner S, Swetter SM.
    J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
    [Abstract] [Full Text] [Related]

  • 6. Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study.
    Abdel-Rahman O.
    Clin Genitourin Cancer; 2017 Oct; 15(5):e747-e754. PubMed ID: 28314541
    [Abstract] [Full Text] [Related]

  • 7. Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea.
    Cho YY, Lim J, Oh CM, Ryu J, Jung KW, Chung JH, Won YJ, Kim SW.
    Cancer; 2015 Jan 15; 121(2):259-68. PubMed ID: 25223713
    [Abstract] [Full Text] [Related]

  • 8. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
    Teng CJ, Hu YW, Chen SC, Yeh CM, Chiang HL, Chen TJ, Liu CJ.
    J Natl Cancer Inst; 2016 Feb 15; 108(2):. PubMed ID: 26538627
    [Abstract] [Full Text] [Related]

  • 9. Risk of subsequent primary thyroid cancer after another malignancy: latency trends in a population-based study.
    Lal G, Groff M, Howe JR, Weigel RJ, Sugg SL, Lynch CF.
    Ann Surg Oncol; 2012 Jun 15; 19(6):1887-96. PubMed ID: 22227921
    [Abstract] [Full Text] [Related]

  • 10. Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers.
    Chuang SC, Hashibe M, Yu GP, Le AD, Cao W, Hurwitz EL, Rao JY, Neugut AI, Zhang ZF.
    Cancer Lett; 2006 Jul 08; 238(1):42-52. PubMed ID: 16039041
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
    Hisada M, Chen BE, Jaffe ES, Travis LB.
    J Natl Cancer Inst; 2007 Feb 07; 99(3):215-22. PubMed ID: 17284716
    [Abstract] [Full Text] [Related]

  • 14. Risk of second malignancies among survivors of pediatric thyroid cancer.
    Adly MH, Sobhy M, Rezk MA, Ishak M, Afifi MA, Shafie AE, Ali MA, Zekri W, Alfaar AS, Rashed WM.
    Int J Clin Oncol; 2018 Aug 07; 23(4):625-633. PubMed ID: 29492793
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH.
    Arch Dermatol; 2007 Jan 07; 143(1):45-50. PubMed ID: 17224541
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Second primary cancer after major salivary gland carcinoma.
    Hirvonen K, Rantanen M, Haapaniemi A, Pitkäniemi J, Malila N, Mäkitie AA.
    Head Neck; 2018 Feb 07; 40(2):251-258. PubMed ID: 28960648
    [Abstract] [Full Text] [Related]

  • 20. Risk of second primary thyroid cancer in cancer survivors.
    Yuan Y, Sun P, Xiao H, Li L, Li J, Ai X.
    Sci Rep; 2024 May 30; 14(1):12478. PubMed ID: 38816510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.